Stay updated on Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial

Sign up to get notified when there's something new on the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    New history entry 'Revision: v3.4.2' was added and an earlier 'Revision: v3.4.1' entry plus a site-wide funding notice were removed. These changes affect only the history metadata and do not modify study data or core page content.
    Difference
    0.7%
    Check dated 2026-02-11T20:36:51.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The additions include a site-wide notice about government funding status and a new revision label (v3.4.1), and the previous revision (v3.4.0) was removed; these are metadata changes and do not affect the study's record content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-04T10:54:01.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Changes are UI/formatting updates (glossary display option, color-coded highlights for additions and deletions, and the revision label updated to v3.4.0); there is no impact on core study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-01-28T07:24:35.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The record history shows a new Revision: v3.3.4 replacing the previous v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:49:40.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    A new revision entry (v3.3.3) was added to the record history, and the HHS Vulnerability Disclosure and a prior revision link were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T21:20:22.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The page history shows a new revision entry v3.3.2 and removes v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:26:51.000Z thumbnail image

Stay in the know with updates to Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page.